A federal district court judge will hear oral arguments July 7 on a preliminary injunction against FDA in a suit brought by Amarin Pharma Inc. challenging the constitutionality of the agency's regulations that prohibit the drug maker from giving physicians truthful and non-misleading information on its prescription drug Vascepa. Amarin is asking U.S. District Court Judge Paul Engelmayer of the U.S. District Court for the Southern District of New York, to grant the injunction because it argues that it is...